Aurum USA
Creating ahealthier worldfor future generations
Aurum USA is the Washington DC-based, non-profit, arm of the organization’s global network. Co-led by dedicated in-country staff, Aurum USA provides:
Expert management of African based projects on behalf of grant or donor agencies and individuals, including guiding program implementation, monitoring and evaluation, and audit and reporting.
A US base for collaborators (academic institutions, researchers, businesses) on projects in sub-Saharan Africa, enabling an effective and efficient administrative hub that supports US-based participants and adjunct activities.
Our Impact
IMPAACT4 TB is a groundbreaking global initiative designed to slow and stop the increase of new TB cases by preventing latent TB infections—the hidden stage fuelling the global TB epidemic. IMPAACT4TB introduced safer, shorter treatment options that make treatment easier and more accessible to the most vulnerable.
Led by the Aurum Institute, the IMPAACT4TB consortium targeted people living with HIV, children under five, and other close contacts of TB patients across 12 high-burden countries accounting for half of the world’s TB burden. The rollout of short-course preventative therapy dramatically reduced the number of new TB cases and saved lives.
3HP have been purchased across
104 countries worldwide
from $72 in 2017 to
$9,99 in 2024
Protecting children from TB – the Dolphin Kids Study
When Cyprion Mpume Makhanya learned about the DOLPHIN Moms clinical trial, she was pregnant with her daughter and fearful of the unknown. Could participating in the study really protect her baby from TB?
With the support of The Aurum Institute and Unitaid, Cyprion became the first participant in the DOLPHIN Moms study, which evaluates the safety and effectiveness of a short-course TB preventive therapy (TPT) regimen during pregnancy.
The study’s findings have been critical in shaping global policy, proving that TB prevention for pregnant women is not just possible—it is lifesaving.
“It was so scary, because you know when you are pregnant, you don't know how it will go to the child, how it will happen. And now I'm just here with my little girl, she’s six months old, and we are healthy.”
- Cyprion Mpume Makhanya
Where We Work | Our Footprint
Contact Us: The Aurum Institute USA, 535 Park Avenue Apt 1-C, New York, NY 10065 John Hamilton, US Lead, jhamilton@auruminstitute.org, +13106896639
Aurum USA Personnel
Adjunct Professor Dave Clark
is the Group Chief Executive Officer (CEO) and an executive director and board member of The Aurum Institute.
Prof. Edward is the Group Chief Operating Officer
at The Aurum Institute. He has been a basic sciences researcher since 2000 and has been involved in clinical research management since 2005. He is highly experienced in working with various international donors and delivering various projects simultaneously.
Margaret McCluskey
serves as Aurum USA’s Senior Strategic Advisor, and her background includes leading HIV vaccine research for the United States Agency for International Development, the Vaccine Research Center at the National Institutes of Health, and the Johns Hopkins University
John Hamilton
is the US Lead for Aurum USA. His experience includes managing grants, (Country Director for EQUIP Malawi), and academic institutions, (Assistant Provost - Chief of Staff position – for UCLA).
Partners
